Inactive Instrument

Calendar Bachem Holding AG Swiss Exchange

Equities

BANB

CH0012530207

Chart calendar Bachem Holding AG

a6fc0.5BF4MY31GR7HaZFVGdcidm43GbHZ8oLDGuUJuCa9HtE.i1wiBumEcGuzIME0L6BWPiYFd-SBts7yI7xC1WWPXZCmIg5cv8JaXYQ85g~99d370a94d63025080abd999de8f7fd4

Upcoming events on Bachem Holding AG

14/05/2024 TIDES USA Conference
24/06/2024 International Oligonucleotides and Peptides Conference
26/06/2024 RNA Therapeutics Symposium
15/07/2024 Nucleic Acids Therapeutics Society of Japan Meeting
24/07/2024 BIO Asia Taiwan Conference
25/07/2024 10:30 am Q2 2024 Earnings Release
22/08/2024 Peptide Therapeutics Forum
25/08/2024 EPS- European Peptide Symposium
16/09/2024 Boulder Peptide Symposium
17/09/2024 Nordic Life Science Days
06/10/2024 Oligonucleotide Therapeutics Society Meeting
09/10/2024 EPFL Forum
04/11/2024 BIO Europe Conference
12/11/2024 TIDES Europe Conference
18/11/2024 American Pharma Manufacturing & Outsourcing Summit

Past events on Bachem Holding AG

26/04/2024 Ex-dividend day for final dividend
26/04/2024 Ex-dividend day for Distribution from share premium account
24/04/2024 Annual General Meeting
22/04/2024 Swiss Biotech Day
19/03/2024 TIDES Asia Conference
18/03/2024 BioEurope Spring Conference
13/03/2024 Biologics UK Congress
13/03/2024 RNA Leaders Europe Congress
07/03/2024 03:30 pm Q4 2023 Earnings Call
07/03/2024 11:30 am Q4 2023 Earnings Release
27/07/2023 05:30 pm Q2 2023 Earnings Call
27/07/2023 10:30 am Q2 2023 Earnings Release
21/04/2023 Ex-dividend day for final dividend
21/04/2023 Ex-dividend day for Distribution from share premium account
07/03/2023 03:30 pm Q4 2022 Earnings Call
07/03/2023 11:30 am Q4 2022 Earnings Release
20/09/2022 05:30 pm Capital Markets Day
25/08/2022 05:30 pm Interim 2022 Earnings Call
25/08/2022 Interim 2022 Earnings Release
05/05/2022 Split: 5 of 1

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million CHF
Released
Forecast
Spread
314
312
0.47%
402
387
4%
503
510
-1.35%
532
533
-0.27%
577
559
3.3%

620

EBITDA
Million CHF
Released
Forecast
Spread
87,2
88,1
-1.02%
123
115
6.82%
157
163
-3.58%
161
164
-2.03%
167
162
3.13%

181

EBIT
Million CHF
Released
Forecast
Spread
62,4
63,9
-2.42%
96,7
87,4
10.69%
129
134
-3.77%
127
131
-3.12%
129
121
6.53%

141

Earnings before Tax (EBT)
Million CHF
Released
Forecast
Spread
60,4
63,1
-4.3%
91,0
86,0
5.81%
131
134
-1.95%
112
121
-7.5%
124
122
1.89%

148

Net income
Million CHF
Released
Forecast
Spread
54,2
53,3
1.61%
78,1
71,9
8.59%
115
113
1.66%
101
104
-3.59%
112
107
5.03%

127

EPS
CHF
Released
Forecast
Spread
3,91
3,84
1.78%
5,58
5,15
8.43%
8,09
7,94
1.85%
1,37
1,44
-5.01%
1,50
1,44
4.53%

1,60

Announcement Date13/03/2012/03/2118/03/2207/03/2326/02/24-

Quarterly results

Fiscal PeriodDecember 2019 S2 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2
Net sales
Million CHF
Released
Forecast
Spread
179
175
2.22%
177
141
25.72%
225
213
5.69%
239
237
0.86%
264
276
-4.46%
235
250
-5.88%
297
299
-0.63%
240
231
3.97%

325

EBITDA
Million CHF
Released
Forecast
Spread
50,7
50,1
1.2%
53,0
39,4
34.52%
69,6
65,8
5.78%
75,5
73,5
2.72%
81,9
90,0
-9%
67,3
76,2
-11.73%
93,2
96,7
-3.57%
52,5
54,7
-3.98%

113

EBIT
Million CHF
Released
Forecast
Spread
37,9
37,5
1.18%
40,3
26,4
52.5%
56,4
49,8
13.33%
61,9
59,0
5%
67,0
73,7
-9.16%
51,6
59,8
-13.79%
75,7
80,1
-5.48%
34,8
36,4
-4.35%

88,8

Earnings before Tax (EBT)
Million CHF
Released
Forecast
Spread















40,4
58,9
-31.49%
71,7
74,5
-3.73%
36,9
35,1
5.18%



Net income
Million CHF
Released
Forecast
Spread



32,8
22,1
48.56%
45,3
40,8
10.95%
53,1
50,2
5.82%
61,6
62,6
-1.63%
36,6
53,3
-31.24%
64,1
66,6
-3.73%
34,4
28,2
22.02%

76,5

EPS
CHF
Released
Forecast
Spread



2,35
1,58
48.73%
3,23
2,92
10.62%
3,80
3,59
5.85%
4,29
4,39
-2.28%
0,50
0,54
-6.83%
0,87
0,93
-6.45%
0,46
0,38
22.12%

1,02

Announcement Date13/03/2021/08/2012/03/2127/08/2118/03/2225/08/2207/03/2327/07/23-